943 results on '"Erez N"'
Search Results
2. An Asymmetric Sparse Telescope
3. Optical amplification for astronomical imaging at higher resolution
4. Phasing a deployable sparse telescope
5. Capture of free-floating planets by stellar systems
6. In Vivo Screen Identifies Liver X Receptor Alpha Agonism Potentiates Sorafenib Killing of Hepatocellular Carcinoma
7. Experimental Evaluation of Deteriorated CMPs Retrofitted by Different Non-invasive Approaches
8. Beyond the diffraction limit via optical amplification
9. Simulated annealing in application to telescope phasing
10. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
11. Enhancing retinal images by nonlinear registration
12. Spectroscopic identification of habitable extra-solar planets
13. Fainter and closer: finding planets by symmetry breaking
14. Path-phase duality of an interfering particle with translational-internal entanglement
15. MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
16. Off-Line, Multi-Detector Intensity Interferometers I: Theory
17. Off-Line, Multi-Detector Intensity Interferometers II: Implications and Applications
18. Another Look at Quantum Teleportation
19. Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600–mutant metastatic melanoma
20. TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma
21. Supplementary Figure 8 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
22. Supplementary Figure 3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
23. Supplementary Figure 2 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
24. Supplementary Figure 5 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
25. Supplementary Figure 4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
26. Supplementary Figure 1 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
27. Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
28. Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells
29. Table S4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
30. Supplementary Figure Legends from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
31. Data from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
32. Supplementary Figure 6 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
33. Supplementary Figure 7 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
34. Mesenchymal Stem/Stromal Cells: BIOLOGICAL THREAT AGENT RICIN INTOXICATION OF THE LUNGS IS EFFECTIVELY TREATED BY MESENCURE, A PROFESSIONALIZED ALLOGENEIC MESENCHYMAL CELL THERAPY, PREFERABLY VIA THE SUBCUTANEOUS ROUTE
35. MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
36. Data from Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells
37. Supplementary Table from Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells
38. Supplementary Figure from Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells
39. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
40. Table S3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
41. Supplementary Figure Legends from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
42. Supplementary Figure 4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
43. Supplementary Figure 2 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
44. Supplementary Figure 5 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
45. Data from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
46. Supplementary Figure 6 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
47. Supplementary Figure 1 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
48. Supplementary Figure 8 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
49. Supplementary Figure 3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
50. Supplementary Figure 7 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.